89bio, Inc. Rings The Closing Bell

ABOUT THIS EVENT

89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, rings the Nasdaq Closing Bell remotely from across the country.

Rohan Palekar, CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore